NovoCure’s patent describes an apparatus for delivering tumor treating fields (TTFields) to a subject’s body. It features multiple electrode sets and temperature sensors that monitor overheating, allowing selective activation or deactivation of electrodes to optimize treatment while preventing damage from excessive heat. GlobalData’s report on NovoCure gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on NovoCure, Neuromodulation implants was a key innovation area identified from patents. NovoCure's grant share as of July 2024 was 28%. Grant share is based on the ratio of number of grants to total number of patents.
Apparatus for delivering tumor treating fields with temperature control
The patent US12029898B2 describes an innovative apparatus designed for applying an alternating electric field to a subject's body. This apparatus consists of multiple sets of electrode elements, each set containing at least two adjacent electrodes. It features a support structure that secures these electrode sets against the subject's body, along with a series of temperature sensors that monitor the temperature of each electrode set. The apparatus is engineered to prevent overheating by adjusting the duty cycle of the alternating current (AC) signal applied to each electrode based on the temperature readings, ensuring safe operation during use.
Additionally, the claims outline that the electrode elements can be arranged concentrically and may include between 9 to 25 sets. The apparatus incorporates electrically controlled switches that manage current flow to the electrodes, allowing for individual control based on temperature feedback. The system is designed to maintain electrode temperatures below 41°C and can proactively adjust duty cycles to equalize temperatures across all electrodes. This technology aims to enhance the safety and efficacy of treatments involving alternating electric fields, potentially benefiting various medical applications.
To know more about GlobalData’s detailed insights on NovoCure, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
